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Multiplexing of fluorescent biosensors and optogenetic systems in live-cell imaging requires spectrally compatible imaging probes. Previously, FRET biosensors based on cyan fluores-
cent protein (CFP) and yellow fluorescent protein (YFP) of the green 
fluorescent protein (GFP)-like family have been multiplexed with cel-
lular reporters based on NIR organic dyes1,2 and with FRET biosen-
sors with orange and red fluorescent proteins (FPs), which require 
specialized imaging methods because of their substantial spectral 
overlap with the CFP–YFP pair3–6. CFP–YFP biosensors also cannot 
be used simultaneously with many optogenetic tools, including light-
oxygen-voltage (LOV), cryptochrome-2 and channelrhodopsins7,8, all 
of which are activated with blue–green light. Several NIR FPs have 
been developed9. However, these spectrally resolvable NIR fluores-
cent proteins (iRFPs) are dimers, a characteristic limiting their use in 
FRET biosensors. Recently, three monomeric iRFPs (miRFPs) have 
been reported10, but the most blue-shifted and red-shifted monomeric 
NIR FPs do not yield efficient FRET pairs, because of their substantial 
spectral cross-talk. To achieve better FRET compatibility, a more red-
shifted monomeric NIR FP is required.
FRET biosensors for Rho GTPases have been instrumental in 
studying this important class of signaling proteins. Rho GTPases 
are molecular switches11 that are activated by the release of GDP 
and the loading of GTP, a process catalyzed by upstream regulator 
G-nucleotide exchange factors (GEFs)12. When on, Rho GTPases 
bind their effectors and propagate signals regulating cellular func-
tions. Binding to GTPase-activating protein (GAP) accelerates the 
hydrolysis of GTP to GDP, thereby turning off the GTPases. The 
G-nucleotide dissociation inhibitors (GDIs) are negative regula-
tors that bind and chaperone Rho GTPases away into the cytosol13. 
Understanding the molecular regulation of Rho GTPases is clearly 
important because their roles are critical both in normal cellular func-
tions and in many diseases14. Importantly, Rho GTPases exist in coor-
dinated signaling networks with rapid spatiotemporal dynamics1. 
To better understand such coordination, new NIR-FRET pairs of FPs 
are required that enable simultaneous probing of multiple processes 
and provide the ability to perturb and simultaneously observe dif-
ferent Rho GTPase pathways in a cell.
Here we describe the most red-shifted monomeric NIR FP to 
date, miRFP720. In mammalian cells, miRFP720 is the brightest 
among the available monomeric NIR FPs developed from bacterial 
phytochromes. We demonstrated the use of miRFP720 in various 
expression tags and characterized it as an effective FRET acceptor 
for the previously described blue-shifted NIR FP miRFP670 (ref. 10), 
thus yielding what is, to our knowledge, the first fully NIR FRET 
pair. Using this pair, we engineered a genetically encoded, single-
chain, monomeric NIR-FRET biosensor for Rac1 GTPase with 
excellent brightness and signal dynamic range. We multiplexed the 
NIR Rac1 biosensor with several CFP–YFP FRET biosensors and 
with a LOV-based optogenetic tool for simultaneous detection and 
perturbation of Rho GTPase activity in single living cells. First, 
with the NIR Rac1 biosensor and a CFP–YFP RhoA biosensor15, we 
directly visualized a Rac1–RhoA antagonism in motile cells, which 
was dependent on the RhoA–ROCK pathway. Second, with the NIR 
Rac1 biosensor and a CFP–YFP biosensor for Rac1–GDI binding2, 
we found a tight spatiotemporal regulation of Rac1 and observed 
a previously undescribed coexistence of activated Rac1 and GDI-
bound Rac1 in specific cellular regions within edge protrusions. We 
then modified the LOV-TRAP optogenetic tool16 to achieve higher 
Rac1 specificity and demonstrated the ability of the NIR Rac1 bio-
sensor to continuously measure Rac1 activity during photoacti-
vation followed by dark relaxation. Finally, we extended the NIR 
technology to kinase biosensors targeting protein kinase A (PKA) 
and c-Jun N-terminal kinase (JNK). We demonstrated that this 
NIR-FRET pair of FPs is generally applicable to biosensor develop-
ment and is highly compatible with existing CFP–YFP biosensors 
and blue–green optogenetic tools.
Results
Engineering and characterization of miRFP720. To develop a 
monomeric NIR FP-based FRET acceptor, we turned to the most 
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NIR-shifted dimeric FP, iRFP720, engineered from the PAS–GAF 
domains of the RpBphP2 bacterial phytochrome9. Because the 
crystal structure of iRFP720 has not yet been determined, we ana-
lyzed the structure of the PAS–GAF domains of RpBphP2 (ref. 17). 
These domains were crystallized as a dimer with a dimerization 
interface formed by the C-terminal helices of both GAF domains. 
Specifically, amino acid residues L309, Q312, V313 and W316 
(Supplementary Results, Supplementary Fig. 1; the subsequent resi-
due numbering follows that in Supplementary Fig. 1) formed hydro-
phobic interactions with their counterparts in the other protomer. 
Importantly, the C-terminal helices of the GAF domains were the 
same in RpBphP2 and iRFP720 and probably formed the dimer-
ization interface in iRFP720. To introduce amino acid substitutions 
into the interface, we considered amino acids at the C termini of 
recently reported monomeric miRFPs developed from different 
bacterial RpBphP1 phytochromes. We hypothesized that substitut-
ing the five amino acid residues in the putative dimerization inter-
face of iRFP720 with charged residues10 should yield a monomeric 
iRFP720 (Supplementary Fig.  1). The resultant iRFP720 E308K 
L309R Q312E V313R W316T mutant was brightly fluorescent and 
had an absorbance maximum at 702 nm and an emission maximum 
at 720 nm (Supplementary Table  1 and Supplementary Fig.  2a,b). 
These maxima are the most NIR shifted among currently available 
monomeric NIR FPs (Fig. 1a,b). Further comparison of this mutant 
with parental iRFP720 and miRFP670 (ref. 10) through analytical 
ultracentrifugation confirmed its monomeric state (Supplementary 
Fig. 3). We termed this mutant miRFP720 and determined that its 
extinction coefficient is 98,000M−1 cm−1, its quantum yield is 6.1%, 
and its pKa value is 4.5 (Supplementary Table 1 and Supplementary 
Fig.  2c). As expected, monomerization did not change the prop-
erties of miRFP720 compared with those of parental iRFP720 
(Supplementary Table 1), because the introduced mutations were at 
the C terminus of the protein, distant from the chromophore pocket 
(Supplementary Fig. 1).
We expressed miRFP720 in HeLa cells and compared its cellu-
lar brightness against that of other miRFPs and parental iRFP720 
(Fig.  1c). The brightness of cytoplasmic miRFP720 was 1.6-fold 
higher than that of cells expressing miRFP670 and 3.9-fold higher 
than that of cells expressing miRFP709 (ref. 10). This result indi-
cated that miRFP720 retains a high efficiency of binding to the 
biliverdin (BV) chromophore in mammalian cells, a property char-
acteristic of the parental iRFP720 (ref. 9). In cells, miRFP720 was 
as bright as iRFP720 (Fig.  1c). The photostability of miRFP720 
in living cells was high and similar to that of previously reported 
miRFPs (Supplementary Table  1 and Supplementary Fig.  2d). 
To test the performance of miRFP720 as a protein tag, we expressed 
several fusions in mammalian cells. Both N- and C-terminal 
fusions localized properly, including with histone 2B, which local-
ized appropriately through mitosis and did not affect cell division 
(Supplementary Fig. 4).
Its high extinction coefficient and NIR-shifted excitation and 
emission spectra make miRFP720, as compared with other miR-
FPs, an advantageous FRET acceptor for a blue-shifted miRFP670 
FRET donor (Supplementary Fig.  5a,b). Importantly, the red-
shifted excitation spectrum of miRFP720 resulted in minimal 
direct cross-excitation of this FP in a FRET pair (Supplementary 
Fig. 5a,b). To test the FRET efficiency of this FP pair, we made a 
miRFP670–miRFP720 fusion connected by a linker containing the 
caspase-3–cleavage site -DEVD- and compared its FRET changes 
after induction of apoptosis with those of the miRFP670 fusion with 
miRFP709 (Supplementary Fig. 5c). In transiently transfected HeLa 
cells, the miRFP670–miRFP720 FRET pair demonstrated a 34% 
change in the donor/FRET ratio after caspase-3 cleavage, whereas 
the miRFP670–miRFP709 FRET pair resulted in a donor/FRET ratio 
of 18%, approximately half that of the miRFP670–miRFP720 FRET 
pair (Supplementary Fig. 5d,e). This result indicated the superiority 
of miRFP720 as a FRET acceptor over miRFP709. To compare the 
miRFP670–miRFP720 FRET pair with standard FRET pairs con-
sisting of GFP-like FPs, we calculated its Förster radius (R0). The 
calculated R0 of 8.3 nm for the miRFP670–miRFP720 FRET pair 
was 1.5 to 1.7 times that of the standard GFP-like FRET pairs, such 
as CFP–YFP (R0 = 4.9 nm) or mCerulean–mVenus (R0 = 5.4 nm)18, 
thus suggesting that substantially longer linkers between FPs and 
sensing parts may be required to design optimal NIR-FRET biosen-
sors. The larger R0 for the miRFP670–miRFP720 FRET pair should 
also lead to higher FRET efficiency in constructs with similar link-
ers. The main reason for the similar FRET efficiencies experimen-
tally observed in the NIR-FRET pair (Supplementary Fig. 5d) and 
GFP-like FRET pair19 is direct cross-excitation of the acceptor. 
Compared with GFP-like FPs, NIR FPs have wider spectra that lead 
to this effect.
NIR Rac1 FRET biosensor using miRFP670–miRFP720. Using 
the new miRFP670–miRFP720 FRET pair, we developed a mono-
meric, single-chain biosensor for Rac1 GTPase. We chose Rac1 
because it has well-recognized roles in Rho GTPase signaling that 
are important in regulating many cellular behaviors. The wide 
availability of biosensors and optogenetic tools for detecting Rho 
GTPases through blue–green–yellow fluorescence should enable 































































































Fig. 1 | Characterization of the engineered monomeric miRFP720. a,b Fluorescence excitation (a) and emission (b) spectra of miRFP720 (magenta) 
overlaid with spectra of other monomeric NIR FPs: miRFP670 (blue), miRFP703 (green) and miRFP709 (red). c, NIR fluorescence brightness in live HeLa 
cells transiently transfected with miRFP720 (magenta, open bars) compared with parental dimeric iRFP720 (magenta, shaded bar) and other monomeric 
NIR FPs: miRFP670 (blue), miRFP703 (green), miRFP709 (red) and mIFP (orange), analyzed through flow cytometry. NIR fluorescence intensity was 
normalized to transfection efficiency (fluorescence intensity of cotransfected EGFP), to the excitation efficiency of each NIR FP with a 635-nm laser, and to 
the fluorescence signal of each NIR FP in the emission filter. Data are shown as mean ±  s.d. (n =  3 independent experiments). A.u., arbitrary units.
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experiments. The design of this biosensor consists of a NIR-FRET 
donor (miRFP670) and a NIR-FRET acceptor (miRFP720) with 
the p21-binding domain (PBD) of p21-activated kinase-1 (PAK1) 
and full-length Rac1 (Fig.  2a)20. In addition to miRFP720, we 
tested the previously reported miRFP703 and miRFP709 (ref. 10) as 
FRET acceptors in several orientations within the biosensor. The 
optimal FRET response was observed with miRFP720 occupy-
ing the ‘FP1’ position and miRFP670 occupying the ‘FP2’ position 
(Supplementary Fig.  6a). To account for the larger Förster radius 
of this NIR-FRET pair (8.3 nm) relative to those of GFP-like FPs, 
we included an additional flexible linker15 (denoted L1; Fig. 2a) and 
optimized for a length of 58 amino acids. At and above that length, 
the FRET ratios from both constitutively active and dominant-
negative versions of the biosensor reached a minimum, but the dif-
ferences between the two mutants were maximized at that length 
compared with shorter linker lengths (Supplementary Fig.  7a). A 
second linker of ten amino acids (denoted L2; Fig. 2a) was included 
(Supplementary Fig. 7b) to minimize FRET in the dominant-neg-
ative version of the biosensor. The final design of the NIR Rac1 
biosensor maintained the native Rac1 C terminus and was able to 
interact with the upstream regulator GDI (Fig. 2b). The PBD affin-
ity was fine-tuned through an autoinhibitory motif that optimized 
sensitivity20, and the use of monomeric components minimized 
spurious intra- and intermolecular interactions affecting localiza-
tion and reversibility.
Fluorometric characterization of the NIR Rac1 biosensor 
revealed a 2.7-fold difference between the on versus the off state of 
the biosensor (Fig. 2b). G12V or Q61L constitutively active mutants 
showed greater FRET than did the wild-type (WT) Rac1 biosen-
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Fig. 2 | NIR Rac1 biosensor for live-cell imaging. a, Schematic of the single-chain NIR Rac1 biosensor design. From N to C terminus: dark red, miRFP720; 
blue, p21-binding domain 1 (PBD1) and p21-binding domain containing H83D H86D (red circles) GTPase-binding-deficient mutations (PBD2); green, linker 
1; red, miRFP670; dark blue, linker 2; gray, full-length Rac1. This orientation enables post-translational isoprenylation of the C terminus, thus maintaining 
the native interaction with appropriate membrane domains and the GDI. GTP versus GDP loading of Rac1 changes the intramolecular conformation and 
affects FRET. b, Representative normalized fluorescence emission spectra of constitutively activated NIR Rac1 biosensor, dominant-negative NIR Rac1 
biosensor and WT NIR Rac1 biosensor expressed with excess GDI. Spectra were measured by excitation of the NIR Rac1 sensor mutants expressed in cell 
suspensions at a 600-nm wavelength, and are from the data analyzed and presented in c, from 5 independent experiments. c, WT or mutant versions 
of NIR Rac1 biosensor with or without fourfold-excess GDI. Data are shown as mean ±  s.e.m. (n =  5 independent experiments). **Significant by two-
tailed Student’s t test; NS, nonsignificant. Exact P values: WT versus G12V, P =  2.626562 ×  10−5; WT versus Q61L, P =  2.158669 ×  10−4; WT versus T17N, 
P =  2.122228 ×  10−3; WT versus T35S Y40C, P =  0.1003134; G12V versus Q61L, P =  0.1877456; WT versus WT +  GDI, P =  2.627320 ×  10−6; G12V versus 
G12V +  GDI, P =  3.684825 ×  10−6; and Q61L versus Q61L +  GDI, P =  0.9049651. d, Representative time-lapse panels of imaging of RhoA and Rac1 in a single 
living MEF (additional time points in Supplementary Fig. 11) from 16 cells from 6 independent experiments. 628/32 and 436/20 excitation filters were 
used for NIR and mCerulean–mVenus FRET excitation, respectively. A 480/40 and 535/30 filter pair was used for the mCerulean–mVenus FRET signal, 
whereas a 684/24 and 794/160 filter pair was used for the miRFP670–miRFP720 FRET signal. DIC, differential interference contrast. Bottom row shows 
an overlay of localizations of high Rac1 (yellow) and high RhoA (blue) activities, with regions of colocalization shown in white. Regions of high Rac1 and 
RhoA activities were defined by intensity thresholding the top 2.5% of pixel-ratio values within the image-intensity histogram. Regions and features of 
interest are indicated with matching-colored arrowheads. Scale bar, 20 µ m. Pseudocolor bar corresponds to ratio limits of 1.0–1.55 for Rac1 and 1.0–1.32 for 
RhoA activities (black to red).
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G12V mutant, which bind GDI, but not for the Q61L mutant, which 
cannot bind GDI (Fig.  2c). The T17N dominant-negative mutant 
and the T35S Y40C effector-binding mutant showed attenuated 
FRET (Fig. 2c). Co-expression of the Rac-targeting (Trio) but not 
the Cdc42-targeting (Intersectin) GEFs resulted in increased FRET 
(Supplementary Fig. 6b). Coexpression of p50 Rho GAP attenuated 
FRET, whereas Rap1 GAP, which does not target Rac1, had no effect 
(Supplementary Fig. 6b).
To determine whether effectors of Rac1 might compete for bind-
ing to the activated NIR Rac1 biosensor15, we performed a PBD-
pulldown assay from lysates of cells expressing activated NIR Rac1 
biosensor. The biosensor binds exogenous PBD only when both 
PBDs within the biosensor are mutated20 such that they cannot 
bind to activated Rac1 (Supplementary Fig.  8a). When expressed 
in fibroblasts (MEF/3T3), constitutively active (Q61L) versus dom-
inant-negative (T17N) mutant NIR Rac1 biosensors showed an 
approximately 40% difference in FRET (Supplementary Fig.  8b). 
The slightly elevated FRET in the dominant-negative (T17N) 
mutant is probably attributable to the formation of a stable com-
plex of GTPase and cellular GEF21, a complex similar to the stable 
complexes between GEF and other dominant-negative mutants 
of Rac1 (G15A and D118A)12 and showing the same FRET levels 
(Supplementary Fig. 8c). We applied the synonymous codon modi-
fication to the linkers and PBD domains to prevent homologous 
recombination during transfection and transduction22. To compare 
the activation patterns of Rac1 in the same cell, we then overex-
pressed the new NIR Rac1 biosensor in MEFs together with the 
original Rac1 biosensor based on CFP–YFP20,23 and performed both 
FRET/donor ratio and subtractive FRET-based ratiometric analy-
ses (Supplementary Fig. 9). We thus extended the Rac1 biosensor 
design20,23 to enable dynamic measurement of activity by using only 
NIR wavelengths above 600 nm in living cells.
Simultaneous measurement of Rac1 and RhoA activities. Rac1 
and RhoA GTPases are antagonistic, as demonstrated through 
molecular and biochemical methods24,25. We decided to use the 
NIR Rac1 biosensor with the CFP–YFP RhoA biosensor15 in single 
living cells to directly probe this antagonism in live-cell imaging. 
Cells are sensitive to overexpression of biosensors15; we therefore 
established stable tetracycline-inducible cells expressing both 
RhoA and Rac1 biosensors at levels below those affecting cellular 
motility (Supplementary Fig.  10; representative migrating MEF 
from a time-lapse experiment for RhoA–Rac1 activities in Fig. 2d, 
Supplementary Fig.  11 and Supplementary Video  1). Rac1 activ-
ity was predominantly localized in the lamellipodia at the front 
of the cell, as previously shown with another class of Rac1 biosen-
sor1, and RhoA activity was localized at the retracting tail, in a thin 
band at the leading edge, or at the side edges and at the back of the 
leading-edge protrusion in regions opposite from the direction of 
cell turning.
NIR spectra of the miRFP670–miRFP720 pair showed negligible 
overlap with CFP–YFP (Supplementary Fig.  12a), thus indicating 
clean separation of two biosensor signals. The rate of photobleach-
ing-associated changes in the FRET/donor ratio for the NIR Rac1 
biosensor was minimal over the course of a live-cell experiment, 
as compared with the changes for the CFP–YFP RhoA biosen-
sor (Supplementary Fig.  12b). This result indicated that both the 
donor and acceptor photobleached at similar rates during imaging. 
We tested whether excitation of the NIR Rac1 biosensor at 436 nm 
(the excitation wavelength for the CFP–YFP biosensor) in addition 
to the 628 nm used for excitation of the NIR-FRET donor, might 
affect the photobleaching rate. We measured only a modest effect 
on the FRET/donor ratio when cells were irradiated at 436 nm in 
addition to 628-nm excitation (Supplementary Fig. 12b). This effect 
probably arose from differential excitation of miRFPs at the shorter 
absorption peak near 400 nm (Soret band)  that is common to all 
phytochrome-derived NIR FPs26 (Supplementary Fig.  12c). Thus, 
the new NIR-FRET biosensor is compatible with multiplex imaging 
and requires only minimal correction for photobleaching through 
previous methods27.
For spatiotemporal quantification, we turned to morphody-
namic analysis1 to analyze the activities of RhoA and Rac1 in the 
same cell during edge protrusion. Morphodynamic analysis quan-
tifies periodic cycling of cellular protrusions under steady-state 
conditions1. The leading-edge motion is extracted, and activities 
of RhoA and Rac1 within diffusion-limited ‘measurement-win-
dow segments’ at the edge and at defined distances away from the 
edge are quantified (Methods)1. We used these measurements to 
determine the temporal cross-correlation between RhoA and Rac1 
activities. We found that the activities were strongly and nega-
tively correlated at the leading edge (within a distance of 0–0.9 µ m 
at the edge). This result was consistent with Rac1–RhoA antago-
nism and is, to our knowledge, the first direct characterization 
of this antagonism in the same cell (Fig.  3a). The time differ-
ence between the onset of RhoA and Rac1 activity was approxi-
mately 20 s, in agreement with the previously determined delay 
calculated from separate imaging of two CFP–YFP biosensors of 
Rac1 and RhoA1 (representative morphodynamic maps from the 
leading-edge window segments in Fig. 3b; Supplementary Fig. 13a 
and Supplementary Videos 2 and 3). Mutually exclusive Rac1 and 
RhoA activities were evident during noncyclical, large protrusion–
retraction of the leading edge (Fig. 3b) and in smaller oscillatory 
protrusions (Supplementary Fig.  13a). The negative cross-cor-
relation between RhoA and Rac1 activities at the leading edge 
diminished to below significance in regions away from the edge 
(> 0.9 µ m; Fig. 3a), thus indicating a strong spatial dependence. By 
combining the new NIR Rac1 biosensor with a CFP–YFP RhoA 
biosensor15, we were able to directly measure both Rac1 and RhoA 
activities at the leading edge and provide a quantitative descrip-
tion of the Rac1–RhoA antagonism. Next, we explored a potential 
mechanism by which Rac1–RhoA antagonism was established at 
the edge. Previously, RhoA–ROCK–myosin has been shown to 
balance edge protrusion, wherein this contractile pathway causes 
stalling of the protrusion during edge cycling28. The role of this 
pathway in modulating RhoA and Rac1 activities has previously 
been demonstrated with a set of CFP–YFP biosensors for RhoA 
and Rac1, imaged separately in different cells28. Therefore, we 
sought to directly visualize this balance in RhoA- and Rac1-driven 
edge protrusion by similarly decoupling the mechanism through 
treatment with a ROCK inhibitor (Y-27632) and directly visu-
alizing Rac1 and RhoA activities in the same cell. In agreement 
with the previous model28, the negative cross-correlation between 
RhoA and Rac1 activities at the edge (0–0.9 µ m) changed to a posi-
tive cross-correlation when ROCK was inhibited, but the strength 
of the correlation was not significant (Fig. 3c). Within 0.9–1.8 µ m 
from the edge, the RhoA and Rac1 activities were positively cor-
related and significant (Fig. 3c). In regions further from the edge, 
the trend in positive cross-correlation continued but was not sig-
nificant. The change in cross-correlation between RhoA and Rac1 
resulted from the concomitant activation of Rac1 and RhoA; this 
activation probably prevented the edge from retracting and Rac1 
from being deactivated in the absence of the ROCK–myosin con-
tractility pathway. This effect was visible in a representative set 
of morphodynamic maps from a cell that showed noncyclical, 
large protrusion–retraction: Rac1–RhoA antagonism was ablated, 
and the two activities overlapped (Fig.  3d and Supplementary 
Video 4). In small oscillatory protrusions (Supplementary Fig. 13b 
and Supplementary Videos 3 and 5), cyclical activation of RhoA 
(region 0.9–1.8 µ m) continued when ROCK was inhibited, but 
Rac1 activity remained elevated. These observations suggested 
that the coordination of RhoA and Rac1 via ROCK is criti-
cal in achieving the antagonism, thus suggesting that molecular 
NaTuRE CHEMICaL BIoLoGy | VOL 14 | JUNE 2018 | 591–600 | www.nature.com/naturechemicalbiology594















































0 210 420 630 850 1060 1270 1490 1700 1910 2130
1.4
1.6





































































































0.9 × 1.8 µm
d = 0.9, 1.8, 2.7 µm etc. 
Cell edge tracking
Windows
0.9 × 1.8 µm






























































Fig. 3 | Morphodynamic analysis of Rhoa–Rac1 antagonism. a, Cross-correlation coefficient as a function of time lags between RhoA and Rac1 activities 
at the protruding edge in MEFs. Dashed magenta lines, 95% confidence interval (95% CI) for the cross-correlation function from the edge region (red 
line, 0–0.9 µ m). The time difference between the RhoA versus the Rac1 biosensor response was –19.6 s ±  31.6s (mean ±  95% CI); i.e., the RhoA activity 
onset preceded the Rac1 activity onset by approximately 19.6 s. 95% CIs are omitted from the rest of plots for clarity. The shaded region indicates P >  0.05 
(n =  1,250 individual sampling-window segments measured from 16 cells from 6 independent experiments). b, Example edge-tracking evolution from a 
single cell (top) and associated morphodynamic maps of the velocity and RhoA and Rac1 activities (bottom three panels), from an untreated control MEF. 
The edge velocity, RhoA activity and Rac1 activity measured within window segments at the leading edge of a single representative cell are compiled on 
the y axes and followed over time on the x axes. Scale bar, 10 µ m. Example set taken from total of 16 cells from 6 independent experiments.   
c, Cross-correlation coefficient as a function of time lags between RhoA and Rac1 activities at the protruding edge in MEFs treated with the ROCK inhibitor 
Y-27632. Dashed magenta lines indicate 95% CIs for the cross-correlation function from the region adjacent to the cell edge (blue line, 0.9–1.8 µ m). 95% 
CIs are omitted from the rest of plots for clarity. The shaded region indicates P >  0.05 (n =  990 individual sampling-window segments measured from 18 
cells from 3 independent experiments). d, Example edge-tracking evolution (top) from a single cell and associated morphodynamic maps of the velocity, 
RhoA and Rac1 activities (bottom three panels), from a MEF treated with ROCK inhibitor Y-27632. Scale bar, 10 µ m. Example set taken from 18 cells from  
3 independent experiments. The numbers in the edge-evolution panels in b and d (top) indicate the orientation of the measurement-window segments 
that correspond to the y axes of the morphodynamic maps as shown. Throughout figure, P values were determined by two-tailed Student’s t test.
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pathways regulated by ROCK may be critical in orchestrating this 
coordination. The ability to simultaneously detect Rac1 and RhoA 
activities enabled the direct observation of this phenomenon.
Multiplex imaging of Rac1 activity and Rac1–GDI binding. 
Regulation of Rho GTPases involves three classes of upstream regu-
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Fig. 4 | Morphodynamic analysis of Rac1 activity and Rac1–GDI binding. a, Schematic drawing of the previously reported biosensor for Rac1–GDI binding2. 
The WT Rac1 is attached to the C terminus of the FRET ‘antenna’ that selectively detects the binding of Rac1 to GDI. b, Cross-correlation coefficient as a 
function of time lags between Rac1–GDI binding and Rac1 activity at the protruding edge in MEFs. Dashed magenta lines, 95% CI for the cross-correlation 
function of the edge and the next adjacent region away from the edge (red line, 0–0.9 µ m; blue line, 0.9–1.8 µ m). The time differences between the Rac1–
GDI versus Rac1 biosensor response was –11.9 s ±  23 s (mean ±  95% CI; the Rac1–GDI biosensor response preceded the Rac1 biosensor response) at the 
leading edge (red line) and + 9.6 s ±  25 s (mean ±  95% CI; the Rac1 activity preceded the Rac1–GDI biosensor response) at the region adjacent to the edge 
(blue line). 95% CIs are omitted from the rest of plots for clarity. The shaded region indicates P >  0.05 (n =  827 individual sampling-window segments 
measured from 10 cells from 3 independent experiments). c, Example morphodynamic dataset of a MEF imaged for Rac1 activity and Rac1–GDI binding 
in the same cell. Shown are the edge-tracking evolution (top left) from a single cell and associated morphodynamic maps of the edge velocity (top right), 
Rac1–GDI binding at the edge (middle left) and at the next adjacent region away from the edge (middle right), and Rac1 activity at the edge (bottom left) 
and at the next adjacent region away from the edge (bottom right). Scale bar, 10 µ m. Example set taken from 10 cells from 3 independent experiments. 
The numbers in the edge-evolution panel in c indicate the orientation of the measurement-window segments that correspond to the y axes of the 
morphodynamic maps as shown. Throughout figure, P values were determined by two-tailed Student’s t test.
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least characterized among regulator interactions, but recent studies 
have revealed spatiotemporal dynamics, regulated in part by cellu-
lar kinases13. We took advantage of a recently reported CFP–YFP 
biosensor for Rac1–GDI binding2 (Fig. 4a) and used it for imaging 
together with the NIR Rac1 biosensor in single living cells. We pro-
duced tetracycline-inducible MEFs in which both the NIR Rac1 and 
Rac1–GDI biosensors were stably incorporated and performed live-
cell imaging and subsequent morphodynamic analysis1. The cross-
correlation of Rac1 activity versus Rac1–GDI binding showed a 
high coordination at the leading edge (0–0.9 µ m) and at an adjacent 
region away from the edge (0.9–1.8 µ m), whereas distal regions were 
not correlated (Fig. 4b). At the edge, we observed a strongly negative 
and significant cross-correlation between Rac1–GDI binding ver-
sus Rac1 activation, with an approximately 12-s difference between 
the Rac1–GDI biosensor response and the subsequent NIR Rac1 
biosensor response. This result indicated that during activation of 
Rac1, the release from GDI (loss of CFP–YFP FRET) was quickly 
followed by activation (gain of NIR FRET) in the plasma mem-
brane, presumably through encountering a GEF (Supplementary 
Fig.  14). This timing is similar to that of Cdc42 activation after 
release from GDI2, thus suggesting that GEF-mediated activation 
of GTPases occurs rapidly after the release; hence, the release from 
GDI may be the rate-determining step. This negative cross-corre-
lation was visible in representative morphodynamic maps (Fig. 4c 
and Supplementary Video  6). Interestingly, at an adjacent region 
away from the edge (0.9–1.8 µ m), a strongly positive and significant 
cross-correlation between Rac1–GDI binding and Rac1 activation 
was observed (Fig. 4b). This result indicated that Rac1 activates in 
this region at the plasma membrane but also permits binding by 
GDI (Supplementary Fig. 14). These results are consistent with the 
previous observation that activated Rac1 may be removed from 
signaling pathways by forming a complex with cytoplasmic GDI29. 
Use of the CFP–YFP and miRFP670–miRFP720 FRET biosensor 
combinations enabled the observation of a tight spatiotemporal 
coordination of Rac1 activation and Rac1–GDI interaction in liv-
ing cells, thus revealing the complexity of spatiotemporal regulation 
of Rac1 by GDI.
Compatibility of the NIR Rac1 biosensor with LOV-TRAP. To 
demonstrate the spectral compatibility of the NIR Rac1 biosensor 
with optogenetics systems requiring blue–green light, including 
the Avena sativa phototropin LOV2, we decided to use the recently 
reported LOV-TRAP system16 (Fig. 5a). This system consists of two 
components: mitochondrially targeted LOV2-Jα and the catalytic 
domain of a GEF fused to an affinity monobody evolved to bind 
reversibly to the dark state of LOV2-Jα (ref. 16). Upon irradiation, 
the Jα domain becomes labile, and the monobody dissociates, thus 
releasing the GEF catalytic domain from mitochondrial sequestra-
tion. The released GEF domain activates Rho GTPases with a half-
life of approximately 18.5 s (ref. 16).
We modified the original LOV-TRAP to specifically target Rac1 
activation by exchanging the catalytic GEF domain of Vav2, which 
activates RhoA, Rac1 and Cdc42, for the N-terminal DHPH-SH3 
domain of Trio GEF, which targets Rac1 and another Rac fam-
ily member, RhoG30. We produced tetracycline-inducible MEFs 
expressing the NIR Rac1 biosensor and transiently transfected 
the cells with N-TOM20-mTagBFP2-LOV2wt and mVenus-Zdk1-
TrioDHPH-SH3, at a cDNA ratio of 10:1 (ref. 16). We imaged Rac1 
activity at 10-s intervals and photoactivated the LOV-TRAP at the 
300-s time point with 457-nm light (cycling 4 s on/6 s off) for 300 
s, which was followed by another 300 s of dark relaxation (Fig. 5b, 
Supplementary Fig. 15a and Supplementary Video 7). We observed 
rapid activation of Rac1 when LOV-TRAP was uncaged, and subse-
quent deactivation after cessation of photoactivation (Fig. 5c). The 
original LOV-TRAP containing the GEF domain of Vav2 (ref. 16) 
produced Rac1 activation similar to that of Trio GEF when uncaged, 
but the decay in Rac1 activity during the dark relaxation appeared 























































Fig. 5 | Concurrent measurement of Rac1 activity during LoV-TRaP optogenetics. a, Schematic drawing of the LOV-TRAP system. Mitochondrially 
targeted mtagBFP2–LOV2wt sequesters the GEF domain of interest attached to a Zdk1 molecule (Z) labeled with monomeric Venus fluorescent protein 
(mVn). Upon photoactivation with 457-nm light, mVn–Zdk1–GEF is released and acts on the target GTPase, and this is followed by dark relaxation after 
cessation of illumination. b, Example panel of a MEF undergoing photoactivation of LOV-TRAP and concurrent measurements of Rac1 activity with the NIR 
Rac1 biosensor. NIR-Rac1-biosensor image sets were acquired every 10 s. 457-nm illumination (cycles of 4 s on, 6 s off) was started at 300 s and ended 
at 600 s (additional time points in Supplementary Fig. 15a). Scale bar, 20 µ m. Pseudocolor limits are 1.0 to 1.74 (black to red). Example taken from n =  17 
independent photoactivation experiments. c, Quantification of Rac1 activity measured concurrently with LOV-TRAP–Trio GEF photoactivation. During 
the on phase of the 457-nm illumination, Rac1 activity levels were significantly higher than levels of the control, which received no 457-nm illumination. 
Two-tailed Student’s t test was used to compare Rac1 activity during photoactivation (300–600 s) and dark relaxation (600–900 s) versus the activity 
before photoactivation (0–300 s), as shown in Supplementary Table 2. n =  17 independent photoactivation experiments for LOV-TRAP–Trio GEF; n =  10 
independent mock-photoactivation experiments for the control condition; all data are shown as mean ±  s.e.m.
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promiscuous targeting of Vav2 toward other Rho GTPases; the cel-
lular GAP may be limiting, or other pathways differentially control-
ling GTPases may have been activated. Interestingly, the LOV-TRAP 
did not induce changes in leading-edge movement as a function of 
photouncaging (or during dark relaxation), although Rac1 was acti-
vated (Supplementary Fig.  15c). This observation suggested that 
proper targeting of GEF, via molecular-interaction domains that 
either localize or facilitate assembly of the downstream-effector sig-
naling complex within appropriate cellular compartments, is also 
required in addition to activated Rho GTPase to drive specific cel-
lular phenotypes. These results demonstrated that the NIR Rac1 
biosensor is complementary to, and can be used together with, 
common optogenetics tools controlled by blue–green-light, thus 
newly enabling simultaneous detection and modulation of Rho 
GTPase activities.
Development of NIR kinase biosensors. To demonstrate the gen-
eralizability of our new NIR-FRET pair of FPs, we extended this 
approach to the biosensors AKAR31 and JNKAR32, to detect the 
phosphorylation activity of the kinases PKA and JNK, respectively 
(Fig.  6a). We replaced the original CFP–YFP in the sensors with 
an optimized backbone33 with miRFP670 and miRFP720 at the N 
and C termini of the sensors, and measured the cellular response to 
previously used stimulations31–33 that induce phosphorylation and 
increases in FRET upon PKA activation (Fig. 6b,c) or JNK activa-
tion (Fig. 6d,e). Upon stimulation, the FRET/donor ratio increased 
rapidly and reached a plateau, as previously reported (Fig.  6c,e 
and Supplementary Videos 8 and 9), thus indicating that the new 
NIR-FRET pair of FPs reported here should be useful as a general 
tool to engineer genetically encoded NIR-FRET biosensors for 
live-cell imaging.
Discussion
From parental dimeric iRFP720, we engineered miRFP720, the 
most red-shifted miRFP to date. Moreover, our rationally designed 
site-specific amino acid substitutions in the dimerization interface 
of iRFP720 can be used to monomerize other dimeric NIR FPs9. The 
photochemical characteristics of miRFP720 are comparable to or 
better than those reported for other monomeric NIR FPs10, thus mak-
ing miRFP720 an advantageous protein tag for multicolor imaging. 
The red shift of miRFP720 makes it an ideal FRET acceptor when 
combined with miRFP670, owing to minimal cross-excitation of the 
acceptor and good spectral overlap between donor fluorescence and 
acceptor excitation. No genetically encoded NIR biosensors based 
on FRET had previously been available. miRFP670–miRFP720 
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Fig. 6 | NIR-FRET pair of fluorescent proteins in kinase-substrate biosensors. a, Basic design principle for the PKA31 and JNK32 sensors, modified from 
the original CFP–YFP versions33 to use the NIR miRFP670 (ref. 10) and miRFP720 fluorescent proteins. b, Representative time-lapse images of a HeLa 
cell expressing the NIR AKAR PKA sensor and undergoing stimulation (additional time points in Supplementary Fig. 16a). n =  3 independent stimulation 
experiments. 1 mM dibutyryl cAMP was added at the 10-min time point, and the FRET/donor ratio was monitored for up to 70 min. Scale bar, 20 µ m.  
c, FRET/donor ratio from NIR AKAR, shown as mean ±  s.e.m. Black arrow indicates the time point at which the stimulation was performed. n =  3 
stimulation experiments. Two-tailed Student’s t test was used to determine P values between FRET/donor ratios before (0–8 min) and after (10–70 min) 
stimulation, as shown in Supplementary Table 3. d, Representative time-lapse images of a HeLa cell expressing the NIR JNKAR JNK sensor and undergoing 
stimulation (additional time points in Supplementary Fig. 16b). n =  3 independent stimulation experiments. 1 µ g/ml anisomycin was added at the 10-min 
time point, and the FRET/donor ratio was monitored for up to 70 min. Scale bar, 20 µ m. e, FRET/donor ratio from NIR JNKAR, shown as mean ±  s.e.m. Black 
arrow indicates the time point at which the stimulation was performed. n =  3 independent stimulation experiments. Two-tailed Student’s t test was used to 
determine P values between FRET/donor ratios before (0–8 min) and after stimulation (10–70 min), as shown in Supplementary Table 3.
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the common CFP–YFP pair in a wide range of FRET applications. 
Importantly, the miRFP670–miRFP720 pair allows for multiplex-
ing of blue–green–yellow channels of fluorescence with essentially 
zero spectral overlap, thus enabling cross-talk-free, simultaneous 
imaging with CFP–YFP biosensors34 and modulation with blue–
green optogenetic tools, such as LOV, cryptochrome-2 and 
channelrhodopsins7,8.
Using the miRFP670–miRFP720 pair, we engineered a NIR 
biosensor for Rac1 GTPase. By combining the NIR biosensor with 
well-characterized and widely used CFP–YFP biosensors, we simul-
taneously imaged Rac1 activity with that of its antagonist RhoA, or 
its regulation by GDI in the same cell. Rac1–RhoA imaging revealed 
the antagonistic dynamic of these two canonical GTPases during 
cell-edge movement, a process dependent on ROCK signaling. 
In agreement with a previous model28, ROCK inhibition induced 
robust protrusion and resulted in activation of both GTPases 
in the same place at the same time. This result is consistent with 
the idea that the RhoA–ROCK–myosin pathway acts as a braking 
mechanism that induces stalling of the leading edge during protru-
sion–retraction cycles with appropriate timing28. To achieve this 
braking, the antagonism must be established via recruitment of 
GEF–GAP modules that, through a feedback mechanism from the 
downstream molecular pathways, must be activated at the appro-
priate time and location. Importantly, multiplexed imaging of the 
dynamics of Rac1–RhoA activities suggested that Rac1 directly 
correlated with protrusions, and RhoA directly correlated with 
retractions. This finding was also consistent with measurements 
previously made with CFP–YFP biosensors in a different fibroblast 
cell line28. One study has shown that the onset of Rac1 occurs closer 
in time to the start of edge retraction, whereas that of RhoA is asso-
ciated with edge protrusion1. This apparent difference is attributable 
to the different types of edge protrusions observed in our current 
analysis compared with previous work, as evidenced by the much 
longer oscillatory periodicity observed in this work (120–140 s 
herein versus 90 s in ref. 1; Supplementary Fig. 10). This difference 
may stem from the use of different fibronectin and serum, which 
might have triggered differential signaling pathways23 and changed 
the balance of Rac1–RhoA activities and the dynamics of protru-
sion. The ability to directly observe both Rac1 and RhoA activities 
in the same cell, as shown here, should facilitate detailed analyses of 
the molecular machinery that coordinates the balance of Rac1 and 
RhoA activities driving cell-edge protrusion.
The coordination of GTPase regulation at the leading edge was 
further demonstrated in our study of Rac1–GDI interaction and 
activation by using the NIR Rac1 biosensor in combination with 
the CFP–YFP Rac1–GDI biosensor2. Our experiments showed spa-
tiotemporal coordination of Rac1 activation after its release from 
GDI at the leading edge. A positive cross-correlation observed at 
an adjacent region behind the leading edge indicated that activation 
of Rac1 was followed closely in time by binding to GDI. This result 
was consistent with those from previous studies indicating that GDI 
binds active Rac1 as a mechanism to control Rac1-effector interac-
tion29. Further investigation in this area will be required to reveal 
the mechanism of GDI-mediated recycling and control of active 
Rac1 GTPase, but, to our knowledge, this is the first direct observa-
tion of such localized spatial regulation of Rac1 GTPase.
Blue–green optogenetic tools, similarly to multiplexed biosen-
sors, have not been able to be used together with CFP–YFP biosen-
sors. For LOV2 (ref. 16), the CFP excitation at 440 nm is too close to 
the photouncaging wavelengths. In the original LOV-TRAP char-
acterization16, either the light or the dark mutant of the LOV-TRAP 
optogenetic tool was tested against CFP–YFP biosensors for Rho 
family GTPases16. Here, we demonstrated that the NIR Rac1 bio-
sensor can be used to measure Rac1 activity at the same time as the 
LOV-TRAP approach16. The ability to monitor activity and simul-
taneously perturb a signaling node through optogenetics should 
be valuable in dissecting signal-pathway interdependency. Spectral 
compatibility with NIR biosensors should now enable the use of 
optogenetic tools in direct real-time experiments.
Finally, we demonstrated the generalizability of miRFP720 as an 
excellent FRET acceptor that can be coupled to miRFP670 to pro-
duce genetically encoded NIR-FRET biosensors. These biosensors 
allow researchers to use the NIR-FRET band for direct imaging, 
quantification and control of several signaling pathways in living 
cells. We expect these NIR-FRET probes to be suitable for use in 
vivo in animal-imaging modalities, because their optimal compat-
ibility with light-absorbance characteristics in tissues enables deep 
tissue penetration. Combining functional imaging with noninvasive 
optogenetic modulation enables cell dynamics to be related to meta-
bolic functions at the cell and tissue levels and to behavior at the 
organ and organismal levels.
Methods
Methods, including statements of data availability and any asso-
ciated accession codes and references, are available at https://doi.
org/10.1038/s41589-018-0044-1.
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Methods
Cloning and protein expression. Site-specific mutagenesis of iRFP720 cloned 
in the pBAD/His-B vector was performed with a QuikChange mutagenesis kit 
(Agilent Technologies). LMG194 host cells (Invitrogen) were used for protein 
expression. The pWA23h plasmid encoding HO from Bradyrhizobium ORS278 
(hmuO) under control of the rhamnose promoter was cotransformed with a 
pBAD/His-B plasmid encoding a fluorescent protein9,35. Bacterial cells were 
incubated overnight at 37 °C in RM minimal medium with ampicillin and 
kanamycin. For initiation of protein expression, 0.002% arabinose and 0.02% 
rhamnose were added. After growing for 6–8 h at 37 °C, the cells were incubated at 
18 °C for 24 h. Proteins were purified with Ni–NTA agarose (Qiagen). Protein was 
eluted with PBS containing 100 mM EDTA instead of imidazole. Then the samples 
were desalted with PD-10 desalting columns (GE Healthcare).
Protein characterization in vitro. A FluoroMax-3 spectrofluorometer (Jobin 
Yvon) was used for recording fluorescence spectra, and a Hitachi U-2000 
spectrophotometer was used for absorbance measurements. To determine the 
extinction coefficients, we calculated a ratio between the maximum absorbance 
of the main peak at the Q band and the side peak at the Soret band and assumed 
that the extinction coefficient at the Soret band corresponded to 39,900 M−1 cm−1 
(refs. 36,37). To determine quantum yield, we measured the fluorescence signal of a 
purified protein in parallel with an equally absorbing Nile blue dye (quantum yield 
of 0.27)38 and compared the signal at several dilutions. pH titrations were done 
with a series of buffers (100 mM sodium acetate, 300 mM NaCl for pH 2.5–5.0 and 
100 mM NaH2PO4, 300 mM NaCl for pH 4.5–9.0).
To test NIR FPs for their oligomeric state, we performed analytical 
ultracentrifugation at 20 °C and 58,000 r.p.m. with an Optima XL-I centrifuge 
(Beckman Coulter) with an AN-60Ti rotor and the absorption optics set to 645 nm. 
Sednterp v.20120828beta software was used to calculate the partial specific volume 
of the proteins according to their sequences and the density and viscosity of the 
buffers. The sedimentation parameters were corrected to standard conditions 
(20,w) by using these values. For sedimentation velocity experiments, 350 μ l  
of protein sample and an equal volume of PBS were loaded into two-sector cell 
assemblies with the protein concentration corresponding to A645 ≈ 0.9. Fifty scans 
were collected over the course of a centrifuge run. A subset of scans, beginning 
with those for which a clear plateau was evident between the meniscus and the 
boundary, was selected for time-derivative analysis in DCDT+ v.2.4.2 software39,40.
Mammalian plasmids. To test the brightness of NIR FPs, we transiently 
cotransfected HeLa cells with plasmids encoding EGFP and NIR FP. To construct 
mammalian expression plasmids, we PCR amplified the respective genes encoding 
NIR FPs as AgeI–NotI fragments and swapped them with a gene encoding EGFP in 
the pEGFP-N1 plasmid (Clontech). For example, the miRFP720 gene was swapped 
with the EGFP gene, thus yielding the pmiRFP720-N1 plasmid. The pmIFP-N1 
plasmid was obtained from Addgene (no. 54620).
For protein tagging and labeling of intracellular structures, we swapped a 
gene encoding miRFP720 with a gene for expression of mTagBFP2 fused either 
C terminally (for α -tubulin and myosin) or N terminally (for LifeAct, vimentin, 
LAMP1, H2B and mitochondrial signal)41. For C-terminal fusions, we increased 
the length of the (SGGGG)n linker to 30 amino acids. For N-terminal fusions, the 
linker length was unchanged.
For caspase-3 FRET biosensors, fusions of miRFPP670 with miRFP709 and of 
miRFP670 with miRFP720, containing an 11–amino acid linker with the caspase-
3-recognition site (GGDEVDGPVAT; the recognition site is marked by italics), 
were designed. An miRFP670-encoding gene was PCR amplified with primers 
containing the linker sequence and inserted via the BglII and AgeI restriction sites 
into the pmiRFP709-N1 and pmiRFP720-N1 plasmids, respectively.
For LOV-TRAP optogenetic experiments, we used pTriEX-N-TOM20-LOV2 
and pTriEx-mVenus-Zdk1-VAV2 DHPHC1 (ref. 16), a gift from K. Hahn  
(Addgene plasmid nos. 81009 and 81133) (University of North Carolina  
at Chapel Hill, North Carolina, USA). mTagBFP242 was cloned into pTriEX-N-
TOM20-LOV2 through overlapping PCR with the following primer pairs:  
5′ -gcagaattatacttggtataccatggtgggccgcaacagcgcgat-3′ and  
5′ -tctagatttaaagttcggatcgctg-3′ to amplify the TOM20 fragment;  
5′ -cagcgatccgaactttaaatctagaatggtgtctaagggcgaagagctga-3′ and  
5′ -cctatatgcataattaggatccacttccagaaccattcagcttgtgccccagtttgcta-3′ to amplify 
mTagBFP2; and 5′ -gcaattagcaatgtcaggatccttggctactacacttgaacgtattg-3′ and  
5′ -gcaatgctaatgcatatattctcgagttaaagttcttttgccgcctcatca-3′ to amplify the LOV2 
domain. The full-length N-TOM2-mtagBFP2-LOV2 was ligated into the pTriEX-4 
backbone via the NcoI and XhoI sites. The full-length WT Trio GEF was a gift 
from J. van Buul (University of Amsterdam, Amsterdam, Netherlands). Trio 
DHPH1SH3 (amino acids 1291–1609)43 was amplified and cloned into pTriEX-
mVenus-Zdk1 at the C terminus through overlapping PCR with the following 
primer pairs: 5′ - gcaagattatatgcatattaccatggtgagcaagggcgaggagctgtt-3′ and  
5′ -agatccacttccgaattccttgtacagctcgtccatgccgaga-3′ to amplify mVenus;  
5′ - gtacaaggaattcggaagtggatctatggtggataacaaattcaataaag-3′ and  
5′ -tttaccagatccaccagatccggatccttttggggcctgggcatcgttca-3′ to amplify Zdk1;  
and 5′ - atccggatctggtggatctggtaaaaggaaagagttcataatggctgagct-3′ and  
5′ -gcattatagaacaattaatctcgagttaggcgtcattgctggagacggagagc-3′ to amplify  
the TrioDHPH1SH3 fragment. The product was ligated into pTriEX-4 via the NcoI 
and XhoI sites.
Mammalian cells and transfection. HeLa cells were purchased from the ATCC 
and were not further authenticated or tested for mycoplasma contamination. 
HeLa cells were grown in DMEM supplemented with 10% FBS, 0.5% penicillin–
streptomycin and 2 mM glutamine (Life Technologies/Invitrogen). For microscopy, 
cells were cultured in 35-mm glass-bottom Petri dishes with no. 1 coverglasses 
(MatTek). Transfections of cells with plasmids were performed with either 
Effectene (Qiagen) or Mirus LT1 (MirusBio) transfection reagents. LinXE cells 
(HEK293 derivative; mycoplasma tested)44 were cultured in DMEM supplemented 
with 10% FBS, 1% Glutamax (Invitrogen) and penicillin (100 IU/ml)–streptomycin 
(100 IU/ml). Mouse embryonic fibroblasts (MEF/3T3 tet-OFF; mycoplasma 
tested; Clontech) were cultured in DMEM supplemented with 10% FBS, 1% 
Glutamax (Invitrogen), penicillin (100 IU/ml)–streptomycin (100 IU/ml) and 
neomycin-G418 (1 mg/ml), as previously described15.
Fluorescence of cell suspensions. The fluorescence of uncleaved and cleaved 
caspase-3 FRET biosensors was measured in transiently transfected HeLa cells  
48 h after transfection. To activate biosensor cleavage, we added 2 μ M staurosporin 
to cells grown in six-well plates 6 h before the analysis. Cells were pretreated 
with 25 μ M BV for 24 h before the measurements. Fluorescence spectra of the 
untreated (uncleaved) and staurosporin-treated (cleaved) cell suspensions were 
recorded at 610-nm excitation in a 150-μ l microcuvette and normalized to acceptor 
fluorescence at 670 nm for comparison.
Fluorescence microscopy. Live HeLa cells were imaged with an Olympus IX81 
inverted epifluorescence microscope 48 h after transfection with miRFP720 
fusions. The microscope was equipped with a 200-W metal-halide arc lamp 
(Lumen220 Pro; Prior), a 100× 1.4-NA oil-immersion objective lens (UPlanSApo; 
Olympus) and a Cy5.5 filter set (665/45-nm excitation and 725/50-nm emission). 
The microscope was operated with SlideBook v.4.1 software (Intelligent Imaging 
Innovations).
To determine protein photostability, unfused NIR FPs were cytoplasmically 
expressed in HeLa cells and imaged at determined time periods. The obtained 
raw data were normalized to corresponding absorbance spectra and extinction 
coefficients of the proteins, the spectrum of the 200-W metal-halide arc lamp and 
the transmission of the 665/45-nm photobleaching filter. For determining the 
FRET efficiency in caspase-3-cleavage experiments, 610-nm-wavelength light was 
used for excitation.
NIR Rac1 biosensor. The previously described single-chain FRET-biosensor for 
Rac1, based on mCerulean1–circularly permutated monomeric Venus20,23, was used 
as the backbone for the new NIR Rac1 biosensor. Briefly, miRFP720 and miRFP670 
were synthesized with codon optimization, and conservative point mutations were 
added to remove internal restriction sites and make the constructs compatible 
with the original Rac1 biosensor backbone containing a set of unique restriction 
sites (NcoI, BamHI, HindIII, EagI, NotI, EcoRI and XhoI) and appropriate 
terminal restriction-site sequences. The miRFP720 was placed in the FP1 position, 
and miRFP670 was placed in the FP2 position on the basis of the optimization 
results (Supplementary Fig. 6a). The optimized biosensor backbone contained a 
miRFP720 as the FRET acceptor; two tandem codon-optimized23 PBDs from PAK1 
(amino acid residues 70–149) to achieve autoinhibitory regulation, which were 
separated by a structurally optimized linker (GSGGPPGSGGSG), an unstructured 
linker (L1, 58 amino acid residues) of optimized length based on  
a previously described design45; miRFP670 as the FRET donor; an optimized 10–
amino acid linker (GSGSGSGGEL; L2); and a full-length WT Rac1 (Fig. 2a). The 
second PBD contained H83D and H86D point mutations to render it unable to 
bind to active GTPase. The synonymous modification22 was applied to the two PBD 
domains and repeating units within linker 1 to prevent homologous recombination 
and stabilize expression. The resulting biosensor construct was cloned into the 
pTriEX-4 backbone (Novagen) via the NcoI and XhoI sites. For the stable/inducible 
incorporation of biosensor into the cellular genome, the pRetro-X system was 
used. Biosensor cDNA cassette was cloned into the pRetro-X-Hygro and pRetro-
X-Puro backbones through the Gateway cloning technique (Invitrogen) according 
to the manufacturer’s protocol. For double-positive biosensor transductants, MEFs 
stably and inducibly expressing the RhoA biosensor15 or Rac1–GDI biosensor2 
were transduced with retrovirus containing the expression cassette for the NIR 
Rac1 biosensor under the control of a tetracycline-inducible promoter, but with 
hygromycin resistance. Methods for production of virus, transduction, selection 
and biosensor induction were as described previously46.
Fluorometric characterization of the NIR Rac1 biosensor. Characterization 
of the biosensor response was performed in LinXE cells (HEK293T derivative) 
through transient overexpression of WT or mutant versions of the biosensor, with 
or without the upstream regulators, as described previously15. Briefly, LinXE cells 
were plated on poly-l-lysine (Sigma)-coated six-well plates overnight at 1.25 × 106 
cells/well, then transfected the next day with Lipofectamine 2000 (Invitrogen) 
according to the manufacturer’s protocol. Biosensors were cotransfected at ratios 
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of 1:4 with GDI, 1:4 with GAP or 1:(1–4) with GEFs. The transfection solution 
additionally contained 25 µ M BV. 48 h after transfection, cells were washed in 
PBS, briefly trypsinized and resuspended in cold PBS, the live-cell suspension 
was placed into a cuvet, and fluorescence emission spectra were measured with 
a spectrofluorometer (Horiba-Jobin-Yvon Fluorolog-3MF2). The fluorescence 
emission spectra were obtained by exciting the specimen with 600-nm-wavelength 
light, and the emission fluorescence was scanned between 640 and 750 nm. The 
background fluorescence reading of cells containing an empty vector was used to 
measure light scatter and autofluorescence and was subtracted from the data. The 
resulting spectra were normalized to the peak miRFP670 emission intensity at 
670 nm to generate the final ratiometric spectra.
NIR-Rac1-biosensor pulldown experiments. LinXE cells were plated at a density 
of 1.25 × 106 cells on poly-l-lysine-coated six-well plates. The next day, cells were 
transfected with Lipofectamine 2000 (Invitrogen) according to the manufacturer’s 
protocol. 24 h later, the cells were lysed in a buffer containing 1% NP-40, 20 mM 
Tris, 300 mM NaCl, pH 8.0, 1 mM PMSF and protease-inhibitor cocktail (Sigma). 
Lysates were clarified by centrifugation at 14,000 r.p.m. for 10 min at 4 °C. After 
removal of an ‘input’ fraction, lysates were incubated with PAK1–PBD beads47 
for 1 h at 4 °C with rotation. Samples were washed three times in lysis buffer, 
resuspended in final sample buffer and analyzed by western blotting20.
Western blotting. Cell lysates were resolved on 10% SDS–polyacrylamide gels. 
PVDF membranes were used for blotting. Primary-antibody incubations were 
performed overnight at 4 °C (1:1,000 dilution). Secondary fluorescently conjugated 
antibody (LiCor; 926-32210; goat anti-mouse IRDye800CW) was diluted 1:20,000 
and incubated for 1 h at room temperature. Immunoblots were recorded with an 
Odyssey Imager (LiCor). The primary antibodies used were anti-β -actin (Santa 
Cruz Biotechnology; sc-69879 clone AC-15) and anti-Rac1 (MilliporeSigma 05-
389; clone 23A).
Live-cell multiplexed FRET imaging. On the day of the experiment, MEF cells 
expressing the biosensors were plated at 4.5 × 104 cells per well in standard growth 
medium containing 25 µ M BV onto 25-mm round no. 1.5 coverslips (Warner 
Instruments) previously coated with 10 µ g/ml fibronectin (Sigma) in Dulbecco’s 
PBS for 1 h at room temperature. Cells were time-lapse imaged beginning 2–3 h  
after plating. Cells were imaged in Ham’s F-12K medium without phenol 
red (Crystalgen), sparged with argon gas to remove dissolved oxygen, and 
supplemented with 3% FBS, 10 mM HEPES, Oxyfluor reagent at 1:100 dilution 
(Oxyrase) and 10 mM dl-lactate (Sigma). The imaging medium did not contain 
exogenous BV during experiments. Cells were imaged at 37 °C in a closed 
imaging chamber48. We used standard wide-field microscopy in our live-cell FRET 
experiments, as described previously49.
Biosensor readouts were measured in cells with a custom Olympus IX81-ZDC 
microscope optimized for FRET48. Metamorph v.7.8.13 (Molecular Devices) was 
used to perform image acquisition. For live-cell imaging, images were acquired 
through a 40× -magnification objective lens (Olympus UIS DIC, 40× , 1.4 NA) 
with 2 × 2 camera binning, by using a custom microscope capable of simultaneous 
acquisition of FRET (mCerulean–mVenus FRET) and mCerulean emissions 
through two Coolsnap ES2 cameras (Photometrics) mounted onto the side camera 
port via an optical beam splitter containing a T505LPXR mirror, ET480/40M 
for mCerulean emission and ET535/30M for mVenus FRET emission (Chroma 
Technology). The microscope’s main body prism was replaced with a T555LPXR 
mirror (Chroma Technology) to allow for splitting of longer wavelengths to the 
bottom mounted camera port. A third camera (Coolsnap HQ2; Photometrics) 
was mounted on the bottom port of the microscope via a filter wheel and used 
to acquire DIC and miRFP670 and miRFP720 FRET channels sequentially. The 
associated error due to motion artifacts at the leading edge (6.36 ± 2.6 nm/s 
(mean ± s.d.)) for the control condition in these MEF cells (calculated during 
morphodynamic analysis)1 translated to, on average, 63.6 ± 26 nm positional 
uncertainty within the 10-s time interval of an acquisition cycle. This result was 
within the resolution limit of the acquisition condition, with calibrated pixel 
dimensions at the image plane of 309 nm × 309 nm. In the side-port dual-camera 
system, the relative intensities between the FRET and mCerulean channels were 
balanced by inclusion of a neutral density filter in the FRET channel (ND 0.2 for 
the RhoA biosensor; ND 0.1 for the Rac1–GDI biosensor), so that the ranges of 
brightness in both channels were similar to each other. Illuminations were all 
from a 100-W mercury arc-lamp source. For mCerulean–mVenus FRET, cells 
were illuminated via an ET436/20X band-pass filter (Chroma Technology). For 
miRFP670–miRFP720 FRET, cells were illuminated with an ET628/32X band-pass 
filter (Chroma Technology). For the emissions, an ET480/40M and ET535/30M 
filter pair was used for mCerulean–mVenus FRET (Chroma Technology), and an 
FF684/24 (Semrock) and FF794/160 (Semrock) filter pair was used for miRFP670 
and miRFP720 FRET imaging.
All image channels were aligned before ratiometric calculations through 
pixel-by-pixel matching using a priori calibration and nonlinear coordinate 
transformation to achieve registration, as previously described49. Metamorph 
v.7.8.13 (Molecular Devices) and Matlab (Mathworks) software were used to 
perform image processing and data analysis. Image processing included flat-field  
correction, background subtraction, camera-noise subtraction, nonlinear 
coordinate transformation, threshold masking, ratio calculations and correction 
for photobleaching, as described previously49. The detailed optical specifications 
for the microscope used here have been described elsewhere48. For imaging of 
biosensors, we adjusted the camera acquisition-time duration by targeting to fill 
approximately 80% of the total digitization range of the charge-coupled-device 
circuitry to maximize the dynamic range, by using excitation intensities of  
0.4–1.0 mW at the specimen plane.
Morphodynamic mapping and cross-correlation analysis. Morphodynamic-
mapping and cross-correlation methods were as described previously1. The 
primary assumption at the core of this analysis is that the relationship between 
GTPase activation and the movements of the cell edge during constitutive 
protrusion–retraction cycles is preserved anywhere within the edge of a single 
cell and among all cells within a given population1. This assumption allowed 
us to evaluate the behavior of a small segment of an edge as an independent 
sampling entity and then average such measurements from many segments to 
perform cross-correlational analyses between multiple measurement parameters. 
Briefly, the analysis algorithm first tracks the leading-edge motion through a 
previously described method1. After the leading-edge positions are defined as a 
function of time from a time-lapse series, measurement-window segments are 
defined along the cell edge to measure the parameters of interest within single 
window-segment entities. In this work, we measured two biosensor activities and 
the cell-edge velocity in sampling-window segments of 0.9 × 1.8 µ m constructed 
along the leading edges of cells, and tracked the cell-edge motion during complete 
protrusion–retraction cycles. We have previously determined that this particular 
measurement-window dimension was diffusion limited (minimal diffusional 
mixing of membrane-bound components between adjacent windows, assuming 
a two-dimensional, membrane-bound diffusion constant: at the cell edge, there 
would be very little cytoplasm present) within the time interval of imaging 
(10 s per image), the objective magnification and the pixel dimension of the 
imaging system used1. Thus, by maintaining such a diffusion-limited sampling 
dimension, we ensured that the readout from individual measurement-window 
segments could be treated as independent sampling entities1. By constructing 
many individual, independent measurement-window segments along edges in a 
number of cells from a given population, we achieved sufficient statistical power 
to determine the significance of localization of activities in space and time, as in 
our previous studies1,2,23. Next, measurement-window segments were moved away 
from the leading edge in 0.9-µ m increments to measure two biosensor readouts 
at successively distal regions away from the edge. The extent of coupling between 
changes in the two biosensor activity readouts was determined with the cross-
correlation function xcov in Matlab, and Pearson’s correlation coefficient was 
used to determine the strength of coupling of two biosensor readouts. In addition 
to determining the spatial coupling, this approach also measures the temporal 
relationship between the two measured biosensor readouts. In this work, we 
analyzed n = 1,250 window segments from 16 cells for the control RhoA–Rac1 
multiplex measurements; n = 990 window segments from 18 cells for ROCK-
inhibited RhoA–Rac1 measurements; and n = 827 window segments from 10 
cells for Rac1–GDI binding and Rac1 activity measurements. The numbers of 
individual window segments constructed and total number of cells analyzed 
per cell population/condition were similar to those in previous studies1,2,23. The 
resulting cross-correlation functions were compiled and analyzed with the 2,000× 
bootstrapping of the smooth-spline fit functions from the individual window 
segments to determine the 95% CIs. The autocorrelation function of the leading-
edge-protrusion velocities was used as a measure to indicate the periodicity of 
the intrinsic protrusion–retraction cycles1. This analysis indicated that in all cases 
analyzed, the expression of two biosensors did not alter the basic protrusion 
periodicity from that of the previously published RhoA-biosensor MEF cell line15, 
imaged under current conditions (Supplementary Fig. 10). The morphodynamic 
analysis as used in this work does not separately parse out the behavior of 
biosensor activities as a function of edge protrusion or retraction. Instead, it takes 
the protrusion–retraction as single cycles and produces global cross-correlation 
functions taking into account many cycles of these processes. Thus, we imaged 
steady-state cells, taking advantage of the continuous cycles of protrusion–
retraction that occur at random locations along the cell edge at steady state. This 
measurement enabled us to sample many iterations of protrusion–retraction 
behaviors and build a statistically robust cross-correlation function between the 
two signaling nodes. Future research directions, although beyond the scope of this 
present work, could include parsing out the GTPase behaviors during protrusion 
versus retraction, as well as analyzing the correlative coupling of signaling nodes 
during acute exogenous stimulations.
In relation to the effect of increasing cell volume in regions away from the 
leading edge and how cytoplasmic biosensor accumulation could influence the 
cross-correlation analysis, we expect that the positive cross-correlation observed 
between Rac1 activity and Rac1–GDI binding at the region adjacent to the leading 
edge (Fig. 4) reflects their functional importance, as opposed to a random response 
caused by changes in cytoplasmic volume. Because wide-field imaging was used, 
an increase in cytoplasmic volume could have increased the FRET signal from the 
cytoplasmic accumulation of Rac1–GDI biosensor in complex with the cytoplasmic 
NaTuRE CHEMICaL BIoLoGy | www.nature.com/naturechemicalbiology
© 2018 Nature America Inc., part of Springer Nature. All rights reserved.
ArticlesNATuRE CHEmICAL BIOLOGY
GDI. In contrast, the NIR Rac1 biosensor could have indicated decreased activity 
from the volume dilution effect, in which low FRET signal from the inactive 
and cytoplasmic-partitioned NIR Rac1 biosensor may have diluted the high 
FRET signal from active biosensor in the plasma membrane (this dilution effect 
has previously been modeled by Spiering et al.49). In such a situation involving 
opposing signal modulation, either a negative cross-correlation would be expected, 
or no correlation would be observed if only one of these volume-associated issues 
predominated. Thus, our observation of positive cross-correlation at this location 
suggests binding of more Rac1 by GDI (and accumulation of Rac1–GDI complex 
in increased cytoplasmic volume) as well as activation of Rac1 at this location.
Optogenetic experiments with LOV-TRAP. In experiments using the LOV-
TRAP16 system to target the Trio GEF catalytic domain for Rac1 activation, MEF 
cells stably and inducibly expressing the NIR Rac1 biosensor were transfected 
with the required components. Briefly, MEFs were induced to undergo biosensor 
expression 48 h before the experiment in the presence of 25 µ M BV, through a 
previously described biosensor-induction method46. 24 h after the induction, 
cells were briefly trypsinized, pooled and seeded onto six-well plates at a density 
of 1 × 105 cells/well, and transfected with Fugene 6 reagent (Roche) according to 
the manufacturer’s protocol. A DNA ratio of 10:1 pTriEX-N-TOM20-mtagBFP2-
LOV2 to pTriEX-mVenus-Zdk1-TrioDHPH1SH3 was used. The plasmids were 
premixed at this ratio before the transfection mixture was made according to 
previously published protocols16. Cells were imaged for 24 h after the transfection. 
The imaging system was set up to enable whole-field photoactivation with 457-
nm light that was pulsed every 10 s (4 s on, 6 s off). Cells positive for LOV-TRAP 
expression were visualized and identified with mTagBFP2/mVenus. Cells were 
then imaged without photoactivation for 31 frames at a 10-s interval per frame. 
The photoactivation sequence was initiated between frames 31 and 32, and 
continued at 10-s intervals for 30 additional frames concurrent with the biosensor 
measurements at the same interval. Data were acquired for an additional 30 frames 
after the end of the photoactivation sequence at the same acquisition intervals for  
a total of 90 frames from beginning to end.
NIR kinase biosensors. To clone the NIR JNKAR and NIR AKAR biosensors, 
we used the pJNKAR1EV-NES and pAKAR3EV-NES plasmids33, respectively, 
which were kindly provided by K. Aoki (Kyoto University, Kyoto, Japan). YPet and 
ECFP in the original AKAR and JNKAR constructs were exchanged for miRFP670 
and miRFP720 via the EcoRI/XhoI and NotI/XbaI restriction sites, respectively. 
Fragments encoding NIR sensors were excised with EcoRI/SalI restriction 
endonucleases and inserted into the pcDNA3.1 plasmid.
For imaging of NIR AKAR and NIR JNKAR, HeLa cells were seeded at a 
density of 1 × 105 cells/coverslip in wells of six-well plates onto 25-mm round 
coverslips treated with 10 µ g/ml fibronectin (Sigma) in PBS for 1 h at room 
temperature. Cells were transfected with Fugene 6 reagent (Roche) according to 
the manufacturer’s protocol. 6 h after addition of the transfection mixture to cells, 
the medium was supplemented with 25 µ M BV. 24 h after the transfection, cells 
were serum starved for 8 h in medium containing 0.1% BSA without exogenous 
BV. At the end of starvation, cells were mounted in a live-cell imaging chamber 
atop a microscope stage and imaged at 37 °C under mineral oil. Cells were time-
lapse imaged at 2-min intervals, and DIC and NIR-FRET/donor image pairs were 
acquired at each time point. After the baseline signal response was established for 
10 min in the absence of stimuli, stimulations were performed by addition of 1 mM 
dibutyryl cAMP or 1 µ g/ml anisomycin, for AKAR and JNKAR, respectively. After 
the stimulation, time-lapse imaging was performed for an additional 1 h at 2-min 
intervals. Image processing and analysis of FRET/donor ratio data were performed 
similarly to the procedures used for the NIR Rac1 biosensor, described above. 
Although beyond the scope of the present work, further sensor optimization by 
modulating the dipole coupling angles and changing the lengths and structures of 
the intramolecular linkers may improve the dynamic range of the sensor response, 
as demonstrated here for the NIR Rac1 biosensor.
Flow cytometry. Flow cytometry analysis of NIR FPs was performed with a BD 
LSRII flow cytometer equipped with 488-nm and 640-nm lasers and a set of 
emission filters. 20,000–50,000 events for each cell type were analyzed. To quantify 
cell fluorescence, the mean fluorescence intensity of the double-positive population 
in the NIR channel was divided by the mean fluorescence intensity of the same 
population in the green channel, thus normalizing the NIR signal to transfection 
efficiency.
Statistical analysis. All statistical significance based on P values was determined 
with Student’s t tests. No vertebrate animals were used in this study. No statistical 
methods were used to predetermine the sample size. No randomization was used. 
The investigators were not blinded to allocation during experiments and outcome 
assessment. Statistical tests used are stated in every figure legend with P values as 
appropriate. The data distribution should meet normal distribution requirements. 
No estimate of variation was performed. No preestablished criteria were used to 
determine data inclusion or exclusion.
Code availability. All Matlab codes and Metamorph scripts used have been 
previously published1,2,49 but are also available from the corresponding authors 
upon reasonable request.
Reporting Summary. Further information on experimental design is available in 
the Nature Research Reporting Summary.
Data availability. The data that support the findings of this study are available 
from the corresponding authors upon reasonable request.
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Life Sciences Reporting Summary
Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life 
science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list 
items might not apply to an individual manuscript, but all fields must be completed for clarity. 
For further information on the points included in this form, see Reporting Life Sciences Research. For further information on Nature Research 
policies, including our data availability policy, see Authors & Referees and the Editorial Policy Checklist. 
    Experimental design
1.   Sample size
Describe how sample size was determined. No sample-size calculations were performed. Standard N>3 independent 
experiments were performed for most cases, unless noted in the figure legend.
2.   Data exclusions
Describe any data exclusions. No data were excluded
3.   Replication
Describe whether the experimental findings were 
reliably reproduced.
All attempts at replication were successful.
4.   Randomization
Describe how samples/organisms/participants were 
allocated into experimental groups.
Not applicable, it is not a clinical trial, no animal/human studies involved
5.   Blinding
Describe whether the investigators were blinded to 
group allocation during data collection and/or analysis.
Not applicable, it is not a clinical trial, no animal/human studies involved
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
6.   Statistical parameters 
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the 
Methods section if additional space is needed). 
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same 
sample was measured repeatedly
A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one- or two-sided (note: only common tests should be described solely by name; more 
complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted
A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
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   Software
Policy information about availability of computer code
7. Software
Describe the software used to analyze the data in this 
study. 
Previously published codes written in Matlab and in Metamorph scripts were used 
and referenced in the text. These codes are available by writing to the 
corresponding authors, as stated in those previous publications. Commercial 
software: Sednterp v.20120828 beta, DCDT v.2.4.2, FlowJo 7.6.2, Metamorph 
v.7.8.13.0, and Matlab 2011a were used
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made 
available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for 
providing algorithms and software for publication provides further information on this topic.
   Materials and reagents
Policy information about availability of materials
8.   Materials availability
Indicate whether there are restrictions on availability of 
unique materials or if these materials are only available 
for distribution by a for-profit company.
No restrictions, materials are available by contacting the corresponding authors 
and/or commercial sources.
9.   Antibodies
Describe the antibodies used and how they were validated 
for use in the system under study (i.e. assay and species).
anti-Rac1: MilliporeSigma 05-389, clone 23A, lot#2586803, 1:1000 dilution. 
anti-beta-actin: Santa Cruz Biotechnology; sc-69879 clone AC-15, lot#D1217, 
1:1000 dilution. 
Goat-anti-Mouse secondary antibody-IRDye800: LiCor; 926-32210, lot#C40213-01, 
1:20000 dilution. 
All antibodies were sourced commercially.
10. Eukaryotic cell lines
a.  State the source of each eukaryotic cell line used. HeLa: ATCC, MEF3T3: Clontech, and LinXE: Dr. Klaus Hahn (UNC-Chapel Hill)
b.  Describe the method of cell line authentication used. HeLa cell line was obtained from ATCC and was not additionally authenticated. 
ATCC authenticates cell lines using STR analysis according to the product 
specification webpage.  MEF/3T3 tet-OFF cell line was purchased from Clontech 
and were not additionally authenticated. According to Clontech, MEF/3T3 Tet-Off 
Cells were transiently transfected by electroporation with pTRE2-Luc. Luciferase 
activity in the presence and absence of 1 μg/ml doxycycline (Cat. No. 631311) was 
measured 48 hr later as described in the Tet Systems User Manual. Induction was 
observed to be at least 80-fold when cells were grown in medium containing 
Clontech's Tet System Approved FBS. This indicates that cell line contains the tet-
inducible component that is integrated into the genome. LinXE cell line was 
obtained from Dr. Klaus Hahn (UNC-Chapel Hill) and were not additionally 
authenticated.
c.  Report whether the cell lines were tested for 
mycoplasma contamination.
HeLa cell line was obtained from ATCC and were not additionally tested for 
mycoplasma. LinXE and MEF/3T3 tet-OFF lines were tested for mycoplasma 
contamination and were negative based on the PCR assay performed in house.
d.  If any of the cell lines used are listed in the database 
of commonly misidentified cell lines maintained by 
ICLAC, provide a scientific rationale for their use.
No commonly misidentified cell lines were used.
    Animals and human research participants
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
11. Description of research animals
Provide details on animals and/or animal-derived 
materials used in the study.
No animals were used in the study
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Policy information about studies involving human research participants
12. Description of human research participants
Describe the covariate-relevant population 
characteristics of the human research participants.
No humans subjects were used in the study
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Flow Cytometry Reporting Summary
 Form fields will expand as needed. Please do not leave fields blank.
    Data presentation
For all flow cytometry data, confirm that:
1.  The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
2.  The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of 
identical markers).
3.  All plots are contour plots with outliers or pseudocolor plots.
4.  A numerical value for number of cells or percentage (with statistics) is provided.
    Methodological details
5.   Describe the sample preparation. HeLa cells from ATCC
6.   Identify the instrument used for data collection. BD LSRII
7.   Describe the software used to collect and analyze 
the flow cytometry data.
BD FACS Diva 8.0.1; FlowJo 7.6.2
8.   Describe the abundance of the relevant cell 
populations within post-sort fractions.
Not applicable
9.   Describe the gating strategy used. Initial gates - FSC-A/SSC-A to discriminate cells from debris; then cells were 
gated in FSC-W/FSC-A to discriminate single cells; then cells were gated in 
SSC-W/SSC-A to discriminate live cells. Resulted population were analyzed 
on SSC-A/FITC-A plot to find cells expressing EGFP and NIR-FP. Non-
transfected cells were used for selecting negative population.
 Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
